Home/Filings/4/0000899243-16-030588
4//SEC Filing

Global Blood Therapeutics, Inc. 4

Accession 0000899243-16-030588

CIK 0001629137operating

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 6:01 PM ET

Size

5.8 KB

Accession

0000899243-16-030588

Insider Transaction Report

Form 4
Period: 2016-09-29
Ramos Eleanor
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2016-09-29+9,2869,286 total
    Exercise: $3.40From: 2016-09-29Exp: 2025-04-08Common Stock (9,286 underlying)
Footnotes (1)
  • [F1]On April 9, 2015, the reporting person was granted an option to purchase 37,142 shares of Common Stock under the issuer's 2012 Stock Option and Grant Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On September 29, 2016, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 9,286 of the shares underlying such option.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001629137

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:01 PM ET
Size
5.8 KB